2-METHYL-THIENO-BENZODIAZEPINE FORMULATION
PROBLEM TO BE SOLVED: To provide a pharmaceutically refined formulation containing olanzapine. SOLUTION: The formulation includes olanzapine pamoate or its solvate. The formulation exhibits a prolonged sustained release of more than 7 days and a burst release of less than 15% of the active component...
Saved in:
Main Authors | , , , , , , , , , , , |
---|---|
Format | Patent |
Language | English |
Published |
24.06.2010
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | PROBLEM TO BE SOLVED: To provide a pharmaceutically refined formulation containing olanzapine. SOLUTION: The formulation includes olanzapine pamoate or its solvate. The formulation exhibits a prolonged sustained release of more than 7 days and a burst release of less than 15% of the active component. COPYRIGHT: (C)2010,JPO&INPIT |
---|---|
AbstractList | PROBLEM TO BE SOLVED: To provide a pharmaceutically refined formulation containing olanzapine. SOLUTION: The formulation includes olanzapine pamoate or its solvate. The formulation exhibits a prolonged sustained release of more than 7 days and a burst release of less than 15% of the active component. COPYRIGHT: (C)2010,JPO&INPIT |
Author | SHINKLE SHARON LOUISE MURRAY LINDA CAMERON TUPPER DAVID EDWARD FERGUSON THOMAS HARRY GARVIN STUART JAMES HENDRIKSEN BARRY ARNOLD MASCARENHAS SNEHLATA SINGH DEKEMPER KURT DOUGLAS BUNNELL CHARLES ARTHUR SANCHEZ-FELIX MANUEL VICENTE BROOKS NORMAN DALE ALLEN DOUGLAS JAMES |
Author_xml | – fullname: ALLEN DOUGLAS JAMES – fullname: BROOKS NORMAN DALE – fullname: HENDRIKSEN BARRY ARNOLD – fullname: MASCARENHAS SNEHLATA SINGH – fullname: SANCHEZ-FELIX MANUEL VICENTE – fullname: FERGUSON THOMAS HARRY – fullname: SHINKLE SHARON LOUISE – fullname: GARVIN STUART JAMES – fullname: MURRAY LINDA CAMERON – fullname: DEKEMPER KURT DOUGLAS – fullname: BUNNELL CHARLES ARTHUR – fullname: TUPPER DAVID EDWARD |
BookMark | eNrjYmDJy89L5WTQMtL1dQ3xiPTRDfHwdPXz13Vy9Yvyd_F0jHIN8PRzVXDzD_IN9XEM8fT342FgTUvMKU7lhdLcDEpuriHOHrqpBfnxqcUFicmpeakl8V4BRgaGBobGFkYGFo7GRCkCAKI6Jw8 |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
ExternalDocumentID | JP2010138208A |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_JP2010138208A3 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 12:58:59 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_JP2010138208A3 |
Notes | Application Number: JP20100060704 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20100624&DB=EPODOC&CC=JP&NR=2010138208A |
ParticipantIDs | epo_espacenet_JP2010138208A |
PublicationCentury | 2000 |
PublicationDate | 20100624 |
PublicationDateYYYYMMDD | 2010-06-24 |
PublicationDate_xml | – month: 06 year: 2010 text: 20100624 day: 24 |
PublicationDecade | 2010 |
PublicationYear | 2010 |
RelatedCompanies | ELI LILLY & CO |
RelatedCompanies_xml | – name: ELI LILLY & CO |
Score | 2.7658117 |
Snippet | PROBLEM TO BE SOLVED: To provide a pharmaceutically refined formulation containing olanzapine. SOLUTION: The formulation includes olanzapine pamoate or its... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
Title | 2-METHYL-THIENO-BENZODIAZEPINE FORMULATION |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20100624&DB=EPODOC&locale=&CC=JP&NR=2010138208A |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQMQXVyuZJibqpiUYpuiZpSZa6FsmpibqJlmlJoPMrLQ1SwAtk_cw8Qk28IkwjmBiyYXthwOeEloMPRwTmqGRgfi8Bl9cFiEEsF_DaymL9pEygUL69W4itixq0d2wI2hJooubiZOsa4O_i76zm7GzrFaDmFwSWAx23Z2DhyMzACmpHgw7adw1zAm1LKUCuU9wEGdgCgMbllQgxMKXmCTNwOsOuXhNm4PCFzngDmdDMVyzCoGWk6-sa4hHpoxvi4enq56_r5OoX5e_i6RjlCuybuyoA-3O-oT7gMSdRBiU31xBnD12gpfFwL8Z7BSA50FiMgQXY90-VYFBItQTW58BWiVkisGmVlGKUaAmq8RNTDNMMgS0PMxNJBmk8BknhlZVm4IJMhZvpGpnIMLCUFJWmygJr2JIkOXDIAAAkkXoQ |
link.rule.ids | 230,309,786,891,25594,76906 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5qFetNq1KtjyKSg7DYxDRtDkGaZENa80JSqb2ETZOACLXYiH_f2TXVnnpbdmBfMPvN7Mx8C3Db46jcTxnJmZIRtUh1MpjnjDC9SDl_pd7NRIJsoLkTdTztTWvwvq6FETyh34IcETVqjvpeivt6-f-IZYvcytV9-oZdH49ObNhS5R3LvCRQlWzToFFoh5ZkWcY4koJnIeN0e93BcAd2-5yel9tOLyYvS1luYopzCHsRDrcoj6CWL5rQsNZfrzVh368i3tislG91DHcK8Wnsvnokdkc0CIlJg1loj4Yzir457aA_50888eZ0AjcOjS2X4KTJ3xaTcbSxwIdTqKPvn7egk-uI52iVaAxNqzRTmM4Rn2VyIaPloaln0N4y0PlW6TU03Nj3Em8UPLXh4DcsrhFFvYB6-fmVXyLalumVOKUfAhp8_Q |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=2-METHYL-THIENO-BENZODIAZEPINE+FORMULATION&rft.inventor=ALLEN+DOUGLAS+JAMES&rft.inventor=BROOKS+NORMAN+DALE&rft.inventor=HENDRIKSEN+BARRY+ARNOLD&rft.inventor=MASCARENHAS+SNEHLATA+SINGH&rft.inventor=SANCHEZ-FELIX+MANUEL+VICENTE&rft.inventor=FERGUSON+THOMAS+HARRY&rft.inventor=SHINKLE+SHARON+LOUISE&rft.inventor=GARVIN+STUART+JAMES&rft.inventor=MURRAY+LINDA+CAMERON&rft.inventor=DEKEMPER+KURT+DOUGLAS&rft.inventor=BUNNELL+CHARLES+ARTHUR&rft.inventor=TUPPER+DAVID+EDWARD&rft.date=2010-06-24&rft.externalDBID=A&rft.externalDocID=JP2010138208A |